Orange County’s third largest medical diagnostics and testing company is being acquired by a fast-growing Chicago-based firm using artificial intelligence for precision medicine. Aliso Viejo-based ...
周二,Needham分析师上调了Tempus AI Inc (NASDAQ:TEM)的股票目标价,从之前的$47.00上调至$56.00。该机构维持对公司股票的"买入"评级。 此次调整是在Tempus AI公布超出预期的第三季度业绩之后做出的。然而,公司重申的2024年全年指引以及对Ambry Genetics的收购给股价带来了压力。 Tempus AI的第三季度表现优于市场预期,这促使Needh ...
Tempus announced that it has entered into an agreement to acquire Ambry Genetics, a leader in genetic ... on TipRanks >> Read More on TEM: Tempus AI NewsMORE Related Stocks Indices Commodities ...